Protia Inc. (KOSDAQ:303360)
5,380.00
+170.00 (3.26%)
At close: Feb 27, 2026
Protia Market Cap
Protia has a market cap or net worth of 69.28 billion as of February 27, 2026. Its market cap has increased by 79.93% in one year.
Market Cap
69.28B
Enterprise Value
55.35B
Revenue
13.52B
Ranking
n/a
PE Ratio
18.25
Stock Price
5,380.00
Market Cap Chart
Since December 19, 2018, Protia's market cap has decreased from 78.41B to 69.28B, a decrease of -11.65%. That is a compound annual growth rate of -1.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 69.28B | -13.78% |
| Dec 30, 2025 | 80.35B | 127.74% |
| Dec 30, 2024 | 35.28B | -16.19% |
| Dec 28, 2023 | 42.10B | -45.57% |
| Dec 29, 2022 | 77.35B | 24.57% |
| Dec 30, 2021 | 62.09B | -38.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 488.21B |
| 3billion | 480.23B |
| Cytogen | 142.11B |
| GENINUS | 116.73B |
| HLB Panagene | 105.49B |
| Green Cross Medical Science | 84.36B |
| Seoulin Bioscience | 55.79B |
| GeneMatrix | 48.64B |